ORX.ST
Orexo AB
Price:  
15.30 
SEK
Volume:  
18,648.00
Sweden | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ORX.ST EV/EBITDA

-144.5%
Upside

As of 2024-12-11, the EV/EBITDA ratio of Orexo AB (ORX.ST) is 30.96. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ORX.ST's latest enterprise value is 1,006.08 mil SEK. ORX.ST's TTM EBITDA according to its financial statements is 32.50 mil SEK. Dividing these 2 quantities gives us the above ORX.ST EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative Enterprise Value.

Range Selected
Trailing P/E multiples 4.6x - 11.2x 7.9x
Forward P/E multiples 5.3x - 9.2x 7.2x
Fair Price (9.53) - (3.38) (6.81)
Upside -162.3% - -122.1% -144.5%
15.30 SEK
Stock Price
(6.81) SEK
Fair Price

ORX.ST EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-09 30.96
2024-12-06 31.10
2024-12-05 30.64
2024-12-04 30.85
2024-12-03 30.11
2024-12-02 29.41
2024-11-29 28.39
2024-11-28 27.78
2024-11-27 28.01
2024-11-26 27.76
2024-11-25 25.72
2024-11-22 24.86
2024-11-21 24.70
2024-11-20 24.69
2024-11-19 24.70
2024-11-18 25.18
2024-11-15 25.38
2024-11-14 25.33
2024-11-13 25.53
2024-11-12 25.66
2024-11-11 25.76
2024-11-08 25.93
2024-11-07 26.19
2024-11-06 26.40
2024-11-05 26.29
2024-11-04 26.10
2024-11-01 26.40
2024-10-31 26.17
2024-10-30 26.31
2024-10-29 26.65
2024-10-28 26.40
2024-10-25 26.29
2024-10-24 26.25
2024-10-23 28.39
2024-10-22 29.03
2024-10-21 29.05
2024-10-18 29.11
2024-10-17 29.24
2024-10-16 29.11
2024-10-15 29.11
2024-10-14 29.56
2024-10-11 29.28
2024-10-10 29.58
2024-10-09 29.54
2024-10-08 29.45
2024-10-07 29.68
2024-10-04 30.00
2024-10-03 29.98
2024-10-02 29.92
2024-10-01 29.47